ENFN Enfusion Inc
Price (delayed)
$11.23
Market cap
$1.45B
P/E Ratio
374.33
Dividend/share
N/A
EPS
$0.03
Enterprise value
$1.41B
Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time
Highlights
Enfusion's equity has increased by 36% YoY and by 4.7% from the previous quarter
The gross profit has grown by 17% YoY and by 4.3% from the previous quarter
The debt is up by 32% year-on-year but it has declined by 3.9% since the previous quarter
The EPS has shrunk by 57% YoY and by 25% QoQ
The company's net income has shrunk by 53% YoY and by 15% QoQ
Key stats
What are the main financial stats of ENFN
Market
Valuations
Earnings
Shares outstanding
129M
Market cap
$1.45B
Enterprise value
$1.41B
Price to earnings (P/E)
374.33
Price to book (P/B)
19.72
Price to sales (P/S)
5.13
EV/EBIT
224.63
EV/EBITDA
55.61
EV/Sales
7.02
Revenue
$201.61M
Gross profit
$136.74M
Operating income
$6.16M
Net income
$2.82M
EBIT
$6.3M
EBITDA
$25.43M
Free cash flow
$23.79M
Per share
Balance sheet
Liquidity
EPS
$0.03
EPS diluted
$0.03
Free cash flow per share
$0.26
Book value per share
$0.57
Revenue per share
$2.19
TBVPS
$1.56
Total assets
$143.26M
Total liabilities
$43.72M
Debt
$20.31M
Equity
$73.22M
Working capital
$66.19M
Debt to equity
0.28
Current ratio
3.42
Quick ratio
3.16
Net debt/EBITDA
-1.34
Margins
Efficiency
Dividend
EBITDA margin
12.6%
Gross margin
67.8%
Net margin
1.4%
Operating margin
3.1%
Return on assets
2.2%
Return on equity
4.3%
Return on invested capital
7.7%
Return on capital employed
5.4%
Return on sales
3.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ENFN stock price
How has the Enfusion stock price performed over time
Intraday
-0.53%
1 week
-2.18%
1 month
0.63%
1 year
34.81%
YTD
9.03%
QTD
9.03%
Financial performance
How have Enfusion's revenue and profit performed over time
Revenue
$201.61M
Gross profit
$136.74M
Operating income
$6.16M
Net income
$2.82M
Gross margin
67.8%
Net margin
1.4%
The net margin has dropped by 60% year-on-year and by 18% since the previous quarter
Enfusion's operating margin has shrunk by 54% YoY and by 9% QoQ
The company's net income has shrunk by 53% YoY and by 15% QoQ
Enfusion's operating income has decreased by 48% YoY and by 8% QoQ
Growth
What is Enfusion's growth rate over time
Valuation
What is Enfusion stock price valuation
P/E
374.33
P/B
19.72
P/S
5.13
EV/EBIT
224.63
EV/EBITDA
55.61
EV/Sales
7.02
The EPS has shrunk by 57% YoY and by 25% QoQ
The price to earnings (P/E) is 36% higher than the last 4 quarters average of 275.5
Enfusion's equity has increased by 36% YoY and by 4.7% from the previous quarter
The P/B is 8% more than the last 4 quarters average of 18.2
Enfusion's revenue has increased by 16% YoY and by 3.3% QoQ
ENFN's price to sales (P/S) is 14% higher than its last 4 quarters average of 4.5
Efficiency
How efficient is Enfusion business performance
ENFN's ROE has plunged by 61% YoY and by 20% from the previous quarter
ENFN's ROA has dropped by 61% year-on-year and by 21% since the previous quarter
The company's return on invested capital fell by 37% YoY but it rose by 4.1% QoQ
The ROS fell by 34% YoY but it rose by 3.3% QoQ
Dividends
What is ENFN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ENFN.
Financial health
How did Enfusion financials performed over time
Enfusion's total liabilities has increased by 39% YoY and by 13% QoQ
Enfusion's total assets has increased by 31% YoY and by 6% from the previous quarter
The debt is 72% smaller than the equity
Enfusion's equity has increased by 36% YoY and by 4.7% from the previous quarter
The debt is up by 32% year-on-year but it has declined by 3.9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.